Sort   by:  
 Page size 
UnknownRituximab plus chlorambucil as first-line treatment for chronic lymphocytic leukemia: Final analysis of an open-label phase II study.
Not available
S-EPMC4876343 | biostudies-literature
UnknownDaratumumab plus RVd for newly diagnosed multiple myeloma: final analysis of the safety run-in cohort of GRIFFIN.
Not available
S-EPMC7903234 | biostudies-literature
UnknownDaratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial.
Not available
S-EPMC7441167 | biostudies-literature
UnknownInfluence of real-world characteristics on outcomes for patients with methicillin-resistant Staphylococcal skin and soft tissue infections: a multi-country medical chart review in Europe.
Not available
S-EPMC4164818 | biostudies-literature
UnknownThe CURB65 pneumonia severity score outperforms generic sepsis and early warning scores in predicting mortality in community-acquired pneumonia.
Not available
S-EPMC2117168 | biostudies-literature
UnknownDaratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: final analysis of clinically relevant subgroups in GRIFFIN.
Not available
S-EPMC11231363 | biostudies-literature
UnknownDaratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk.
Not available
S-EPMC11035596 | biostudies-literature
UnknownAntimicrobial stewardship in Scotland: impact of a national programme.
Not available
S-EPMC3436612 | biostudies-literature
UnknownKnee moments of anterior cruciate ligament reconstructed and control participants during normal and inclined walking.
Not available
S-EPMC4054639 | biostudies-literature
UnknownThe Imperial Joint Line Congruency Measurement is a valuable tool in total knee arthroplasty.
Not available
S-EPMC8432761 | biostudies-literature
Sort   by:  
 Page size